---
title: "NHU: Net profit in the third quarter was 1.717 billion yuan, a decrease of 3.80%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263078922.md"
description: "NHU announced that its revenue for the third quarter was 5.541 billion yuan, a decrease of 6.66%; net profit was 1.717 billion yuan, a decrease of 3.80%. Revenue for the first three quarters was 16.642 billion yuan, a year-on-year increase of 5.45%; net profit was 5.321 billion yuan, a year-on-year increase of 33.37%"
datetime: "2025-10-28T12:07:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263078922.md)
  - [en](https://longbridge.com/en/news/263078922.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263078922.md)
---

# NHU: Net profit in the third quarter was 1.717 billion yuan, a decrease of 3.80%

NHU announced that its revenue for the third quarter was 5.541 billion yuan, a decrease of 6.66%; net profit was 1.717 billion yuan, a decrease of 3.80%. Revenue for the first three quarters was 16.642 billion yuan, a year-on-year increase of 5.45%; net profit was 5.321 billion yuan, a year-on-year increase of 33.37%

### Related Stocks

- [002001.CN](https://longbridge.com/en/quote/002001.CN.md)

## Related News & Research

- [Taylor Swift wedding-dress fever puts bridal brands on high alert](https://longbridge.com/en/news/295516470.md)
- [Volare launches share issue as Pori commercial-scale plant comes online](https://longbridge.com/en/news/295769322.md)
- [15:03 ETMNA: MGB Refuses to Schedule More Negotiations or Make Any Proposals to Brigham Nurses in Third Session Following Historic Strike](https://longbridge.com/en/news/295569711.md)
- [CTT Pharma wins US patent for micelle-based nicotine, vitamins, caffeine delivery technology](https://longbridge.com/en/news/295658829.md)
- [Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study](https://longbridge.com/en/news/295661585.md)